Is Very High Thyroid Stimulating Hormone Level Required in Differentiated Thyroid Cancer for Ablation Success?


Creative Commons License

HASBEK Z. , TURGUT B.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, vol.25, no.2, pp.79-84, 2016 (Journal Indexed in ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 25 Issue: 2
  • Publication Date: 2016
  • Doi Number: 10.4274/mirt.88598
  • Title of Journal : MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
  • Page Numbers: pp.79-84

Abstract

Objective: Remnant ablation with radioactive iodine (I-131) is a successful form of treatment that aims to destroy the remaining residual tissue and/or metastatic tissue after total thyroidectomy in differentiated thyroid cancer (DTC) patients. High level of thyroid stimulating hormone (TSH) (>= 30 mIU/L) is recommended for success of ablation treatment. In this retrospective study, our aim was to investigate whether the TSH levels at the time of ablation effect the success of radioactive iodine remnant ablation.